Study Of The Effects Of SB 480848 (Darapladib) On The Electrical Conduction Of The Heart

Summary

This is a study to assess the effects of darapladib on the cardiac conduction of the heart as compared to placebo and moxifloxacin. This a four period crossover design with each period lasting about 10 days. There will be a 7 to 10 day wash out in between each period.

Timeline

Start

2006-12

Primary completion

—

Completion

—

Drugs

Indications